v3.26.1
Debt - Note Purchase Agreement (Details) - Notes
$ in Thousands
6 Months Ended 18 Months Ended
Aug. 06, 2026
USD ($)
Jan. 13, 2025
USD ($)
installment
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
Debt          
Aggregate principal amount     $ 75,000   $ 75,000
Additional issue of principal amount of notes   $ 50,000      
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]   us-gaap:SecuredOvernightFinancingRateSofrMember      
Variable rate (as a percent)   4.29%      
Additional interest rate (%)   3.71%      
Interest rate (as a percent)   9.75%      
Additional increase in interest rate at event of default   5.00%      
Number of equal installments | installment   2      
Financial covenants   The Note Purchase Agreement contains no financial covenants.      
Change in fair value reported in comprehensive loss     $ 2,814 $ 5,300 $ 8,000
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Liability, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration]     Fair Value Adjustment of Notes, Instrument Specific Credit Risk    
Debt issuance costs     $ 700    
Maximum          
Debt          
Aggregate principal amount of notes   $ 150,000      
Initial sale          
Debt          
Aggregate principal amount   75,000      
Second sale, any time prior to December 31, 2025          
Debt          
Additional issue of principal amount of notes   25,000      
Third sale, any time prior to December 31, 2026 (trailing six-month worldwide net sales of avutometinib and defactinib are at least $55.0 million)          
Debt          
Additional issue of principal amount of notes   50,000      
Worldwide net sales of avutobetinib and defactinib during trailing 6-months   $ 55,000      
First 8 Quarters following the Note Purchase Agreement Closing Date          
Debt          
Interest due paid-in-kind (%)   50.00%      
First $100 million net sales of each included product          
Debt          
Participation Percentage   1.00%      
Sales amount   $ 100,000      
Purchased of full $150 million aggregate principal amount of Notes          
Debt          
Participation Percentage   2.00%      
Aggregate principal amount of notes   $ 150,000      
Redemption prior to second anniversary          
Debt          
Debt redemption, percentage of principal amount   135.00%      
Redemption prior to third anniversary          
Debt          
Debt redemption, percentage of principal amount   175.00%      
Redemption after third anniversary          
Debt          
Debt redemption, percentage of principal amount   195.00%      
Subsequent events          
Debt          
Aggregate principal amount of notes $ 75,000        
Participation Percentage 1.00%        
Subsequent events | Initial sale          
Debt          
Additional issue of principal amount of notes $ 50,000        
Subsequent events | Second sale, any time prior to December 31, 2025          
Debt          
Additional issue of principal amount of notes $ 25,000